PMC8035826_01
Histological features of the primary and recurrent tumors. A: Low-power view of the primary cervical adenocarcinoma of usual type, deeply invading the uterine stroma (hematoxylin and eosin 20x). B: High-power view of the carcinoma showing typical cribriform adenocarcinoma glands (hematoxylin and eosin 100x). C: Recurrent tumor at Low-power magnification showing similar growth patterns (hematoxylin and eosin 20x). D: High-power view of the recurrent tumor showing similar histological features to the primary cervical tumor (hematoxylin and eosin 100x).
LS-JSLS200032F001.jpg
PMC8035826_01_LS-JSLS200032F001.jpg
F1
The tumor size measured 1.5 cm with no lymphovascular space invasion (LVSI) and 83% of stromal invasion (Figure 1). Peritoneal washings were negative for malignancy and final pathology was consistent with primary cervical cancer with negative margins (Figure 1).
Pre-operative radiographic studies of port-site metastasis. A: Magnetic resonance imaging of abdomen and pelvis with and without intravenous contrast in 2016. T1- and T2-Weighted axial images demonstrating diffusely enhancing mass measuring 2.0 x 4.1 x 3.1 centimeters, involving the right rectus sheath. B: computed tomography of abdomen and pelvic with intravenous contrast and oral contrast showing 1.7 centimeter right abdominal wall metastatic implant.
LS-JSLS200032F002.jpg
PMC8035826_01_LS-JSLS200032F002.jpg
F2
She underwent abdominal and pelvic imaging, which showed a new hyperdense 4.4 cm mass within the right rectus sheath (Figure 2). NCCN guidelines. Nearly 7 years after her initial diagnosis and 3 years after resection of port-site metastasis, she was diagnosed with a second port-site recurrence on abdominal imaging, which revealed a 1.7 cm right abdominal wall metastatic implant (Figure 2).